Healthtech Series B Investors & VC Firms
1216 firms in this list, with a median first check of $750K. 285 of them lead rounds. Generated from verified public data and updated continuously.
Medical Excellence Capital
New YorkPre-Seed–Series B
17 people
Altara Ventures
SingaporeSeed–Late Stage$3M – $5M
13 people
SQN Venture Partners, LLC
CharlestonSeed–Late Stage
7 people
V-Bio Ventures
GhentSeed–Growth$270K – $2.2M
13 people
Floating Point
CambridgePre-Seed–Series B
9 people
NovaCapital
Seed–Late Stage
9 people
Sandwater
OsloSeed–Series B$2.2M – $11M
12 people
Bamboo Capital Partners
LuxembourgSeed–Growth
22 people
Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
19 people
Bonitás Ventures
BudapestSeries A–Late Stage$540K – $4.3M
19 people
DeepTechXL
EindhovenPre-Seed–Series C$108K – $2.2M
16 people
Lifeforce Capital
Chevy ChaseSeed–Series C$500K – $5M
4 people
WELL Ventures
VancouverSeed–Growth
16 people
SCI Ventures
LondonSeed–Series B
18 people
Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Danone Manifesto Venture
New York CitySeed–Growth
11 people
Wittington Ventures
TorontoSeed–Late Stage
13 people
Brightlands Venture Partners
GeleenSeed–Series B$540K – $2.2M
15 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Impact America Fund
IrvineSeed–Series B$250K – $3M
9 people
OWW Capital Partners Pte. Ltd.
SingaporeSeed–Late Stage$500K – $10M
9 people
Puhua Capital
HangzhouPre-Seed–Late Stage$1.4M – $112M
Related lists
Series B Investors & VC Firms (4094)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Series B Investors & VC Firms in United States (1625)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)
Data sourced from public filings and firms' own websites — see our methodology.






































































